Myocarditis secondary to smallpox vaccination

BMJ Case Rep. 2018 Mar 22:2018:bcr2017223523. doi: 10.1136/bcr-2017-223523.

Abstract

The development of vaccines ushered in the most profound advancement in 20th century medicine, and have widely been regarded as the one of the most important scientific discovery in the history of mankind. However, vaccines are not without risk; reactions can range from injection site reactions to life-threatening anaphylaxis. Among the more serious vaccine-related sequela is myocarditis. Although myocarditis has been reported following many different vaccines, the smallpox vaccine has the strongest association. We report a case of a 36-year-old active duty service member presenting with progressive dyspnoea, substernal chest pain and lower extremity swelling 5 weeks after receiving the vaccinia vaccination. The aetiology of his acute decompensated heart failure was determined to be from myocarditis. Although the majority of cases of myocarditis resolve completely, some patients develop chronic heart failure and even death. Vaccine-associated myocarditis should always be on the differential for patients that exhibit cardiopulmonary symptoms after recent vaccinations.

Keywords: heart failure; pericardial disease; radiology (diagnostics); vaccination/immunisation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Diagnosis, Differential
  • Humans
  • Magnetic Resonance Imaging, Cine
  • Male
  • Military Personnel*
  • Myocarditis / chemically induced
  • Myocarditis / diagnosis*
  • Myocarditis / diagnostic imaging
  • Smallpox Vaccine / adverse effects*
  • Vaccination / adverse effects*

Substances

  • Smallpox Vaccine